Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial - Concepedia

Concepedia

Publication | Open Access

Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial

DOI Full Paper Access

101

Citations

81

References

2022

Year

A. Stewart Campbell, Brittany D. Needham, Christopher R. Meyer, Joanna Tan, Mary C. Conrad, Gregory M. Preston, Federico Bolognani, Srinivas G. Rao, Helen Heussler, Rebecca Griffith,

Nature Medicine

Oral Small-molecule SequestrantPharmacologyClinical TrialsOpen-label Phase 1B/2aMedicineSmall MoleculesAutism Spectrum Disorder

References

	Year	Citations

Page 1

Page 1